Revenue + Forward P/E
Vaxcyte, Inc. (PCVX) quarterly revenue and forward P/E
RevenueRevenue (est)Forward P/E
Valuation
Market cap
$8.61B
Enterprise value
$7.89B
P/E ratio (TTM)
-8.08x
P/S ratio (TTM)
0.00x
P/B ratio
2.59x
EV/Sales
0.00x
EV/EBITDA
-8.57x
Dividend yield
0.00%
Income statement (TTM)
Revenue (TTM)
$0
Gross profit (TTM)
$0
Operating income (TTM)
$-923.68M
EBITDA (TTM)
$-741.77M
Net income (TTM)
$-766.63M
Free cash flow (TTM)
$-669.29M
Margins & returns
Gross margin
0.00%
Operating margin
0.00%
Profit margin
0.00%
Return on equity
-32.51%
Return on assets
-28.27%
Per-share metrics
EPS (TTM)
-$6.78
Dividend yield
0.00%
Beta
1.22
Capital structure
Cash & equivalents
$173.96M
Total debt
$228.84M
Net debt
$54.88M
Shares outstanding
144.40M
Financial health
Current ratio
7.91
Debt / equity
0.09
Debt / assets
0.08
Interest coverage
-
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.15T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $628.65B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $439.33B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $368.33B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $357.68B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $328.31B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $8.61B | -8.08x | 0.00x | -8.57x | - |